5 Stocks Under $30 to Buy Today According to Billionaire Steven Cohen

2. FibroGen, Inc. (NASDAQ:FGEN)

Point72 Asset Management’s Holdings: $70 million

Percentage of Point72 Asset Management’s Portfolio: 0.27%

Number of Hedge Fund Holders: 15

Share price on May 27, 2022: $9.2

FibroGen, Inc. (NASDAQ:FGEN) is a biotechnology company that develops treatments for kidney diseases, dystrophy, cancer, fibrosis, and others. It is based in San Francisco, California, United States.

By the end of its fiscal Q1, FibroGen, Inc. (NASDAQ:FGEN) had brought in $60 million in revenue and -$0.68 in GAAP EPS, pleasing Wall Street by surpassing its estimates for both. The company aims to conduct several drug studies for cancer and other diseases during this year and the next.

Point72 Asset Management held a $70 million stake in FibroGen, Inc. (NASDAQ:FGEN) by the end of this year’s January quarter. This came through 5.8 million shares and represented 0.27% of its investment portfolio. During the same time period, 15 of the 912 hedge funds part of Insider Monkey’s research had also invested in the company.

Guy Levy’s Soleus Capital is FibroGen, Inc. (NASDAQ:FGEN)’s second largest investor. It owned one million shares as Q1 2022 came to an end, and these were worth $12 million.